受强制性开放获取政策约束的文章 - Derek Wong了解详情
可在其他位置公开访问的文章：5 篇
A low-cost, thermostable, cell-free protein synthesis platform for on-demand production of conjugate vaccines
KF Warfel, A Williams, DA Wong, SE Sobol, P Desai, J Li, YF Chang, ...
ACS synthetic biology 12 (1), 95-107, 2022
强制性开放获取政策： US National Science Foundation, Bill & Melinda Gates Foundation, US …
Cell‐free exploration of the natural product chemical space
JW Bogart, MD Cabezas, B Vögeli, DA Wong, AS Karim, MC Jewett
ChemBioChem 22 (1), 84-91, 2021
强制性开放获取政策： US National Science Foundation, US Department of Energy, Swiss National …
The Proteasome as a Drug Target in the Metazoan Pathogen, Schistosoma mansoni
B Bibo-Verdugo, SC Wang, J Almaliti, AP Ta, Z Jiang, DA Wong, CB Lietz, ...
ACS infectious diseases 5 (10), 1802-1812, 2019
强制性开放获取政策： US National Institutes of Health
A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice
AJ Williams, KF Warfel, P Desai, J Li, JJ Lee, DA Wong, PM Nguyen, ...
Frontiers in Molecular Biosciences 10, 1085887, 2023
强制性开放获取政策： US National Science Foundation, Bill & Melinda Gates Foundation, US …
GlycoCAP: a cell-free, bacterial glycosylation platform for building clickable azido-sialoglycoproteins
AH Thames, SJ Moons, DA Wong, TJ Boltje, BS Bochner, MC Jewett
ACS synthetic biology 12 (4), 1264-1274, 2023
强制性开放获取政策： US National Science Foundation, US Department of Defense, US National …
出版信息和资助信息由计算机程序自动确定